Patients with terminal forms of leukaemia and lymphoma who have run out of treatment options could soon benefit from a new drug, which not only puts an end to chemotherapy and has virtually no side effects but also improves a patient’s life expectancy and quality of life.
It has been described as a breakthrough in cancer treatment by a leading professor in haematology, who presented...
